IL1B and breast carcinoma: Studies from the same group (21) showed that, similarly to pancreatic cancer (22), IL-1β, which was released by myeloid DCs under the influence of tumor-derived factors (i.e., alarmins), was key for TSLP secretion by breast cancer cells (Figure 1A).